OBJECTIVE: To evaluate whether EEG performed within 30 min of referral by an ED physician helps establish diagnosis and/or changes management and in which clinical setting. METHODS: Single-center prospective cohort intervention study 1 day/week, of sequentially referred adult patients with clinical seizures or altered mental status (AMS). Standard EEGs were performed by an EEG technician using a commercially available cap, interpreted by an epileptologist, immediately reported to the ED physician and a utility survey completed. Quality and interpretation of 20 min EEGs was compared to pre-specified 5 min segments of each EEG using the kappa coefficient. RESULTS: Over 1 year, 82 patients underwent ED EEG. Tonic clonic seizure activity had occurred in 33%. Mean time for EEG setup was 13.1 ± 6.2 min. EEG assisted the diagnosis in 51%, changed ED management in 4% and would be ordered again if EEG was available in 46%. Positive utility of EEG was significantly associated with toxicologic, psychiatric and endocrine/metabolic causes of AMS vs. other causes (p<0.001) and sudden onset AMS (p=0.007). Independent predictors of whether ED EEG would be ordered if available were witnessed seizures (p=0.01), no prior head trauma (p=0.001) and survey respondent being a physician assistant (vs. MD) (p=0.02). The 5 (vs. 20) min EEG presented good agreement on waveform shape/amplitude (kappa=0.78), artifact (kappa=0.75) and interpretation categories (all kappa levels ≥ 0.70). CONCLUSIONS: Rapid availability of standard full-montage EEG in the ED is feasible and helps establish a diagnosis in about half of AMS patients, but rarely changes management. An abbreviated 5 min full-montage EEG presents adequate reliability which may improve use in the ED. SIGNIFICANCE: Specific presentations of AMS offer the best diagnostic benefit for EEG in the ED.
OBJECTIVE: To evaluate whether EEG performed within 30 min of referral by an ED physician helps establish diagnosis and/or changes management and in which clinical setting. METHODS: Single-center prospective cohort intervention study 1 day/week, of sequentially referred adult patients with clinical seizures or altered mental status (AMS). Standard EEGs were performed by an EEG technician using a commercially available cap, interpreted by an epileptologist, immediately reported to the ED physician and a utility survey completed. Quality and interpretation of 20 min EEGs was compared to pre-specified 5 min segments of each EEG using the kappa coefficient. RESULTS: Over 1 year, 82 patients underwent ED EEG. Tonic clonic seizure activity had occurred in 33%. Mean time for EEG setup was 13.1 ± 6.2 min. EEG assisted the diagnosis in 51%, changed ED management in 4% and would be ordered again if EEG was available in 46%. Positive utility of EEG was significantly associated with toxicologic, psychiatric and endocrine/metabolic causes of AMS vs. other causes (p<0.001) and sudden onset AMS (p=0.007). Independent predictors of whether ED EEG would be ordered if available were witnessed seizures (p=0.01), no prior head trauma (p=0.001) and survey respondent being a physician assistant (vs. MD) (p=0.02). The 5 (vs. 20) min EEG presented good agreement on waveform shape/amplitude (kappa=0.78), artifact (kappa=0.75) and interpretation categories (all kappa levels ≥ 0.70). CONCLUSIONS: Rapid availability of standard full-montage EEG in the ED is feasible and helps establish a diagnosis in about half of AMSpatients, but rarely changes management. An abbreviated 5 min full-montage EEG presents adequate reliability which may improve use in the ED. SIGNIFICANCE: Specific presentations of AMS offer the best diagnostic benefit for EEG in the ED.
Authors: Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch Journal: J Clin Neurophysiol Date: 2015-04 Impact factor: 2.177
Authors: Shahriar Zehtabchi; Samah G Abdel Baki; Ahmet Omurtag; Richard Sinert; Geetha Chari; Shweta Malhotra; Jeremy Weedon; André A Fenton; Arthur C Grant Journal: Am J Emerg Med Date: 2013-09-23 Impact factor: 2.469
Authors: Pasi Lepola; Sami Myllymaa; Juha Töyräs; Taina Hukkanen; Esa Mervaala; Sara Määttä; Reijo Lappalainen; Katja Myllymaa Journal: J Clin Monit Comput Date: 2015-01-10 Impact factor: 2.502
Authors: Shahriar Zehtabchi; Samah G Abdel Baki; Ahmet Omurtag; Richard Sinert; Geetha Chari; Gholamreza S Roodsari; Jeremy Weedon; André A Fenton; Arthur C Grant Journal: Acad Emerg Med Date: 2014-03 Impact factor: 3.451
Authors: Ahmet Omurtag; Samah G Abdel Baki; Geetha Chari; Roger Q Cracco; Shahriar Zehtabchi; André A Fenton; Arthur C Grant Journal: Int J Emerg Med Date: 2012-09-24